CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

Medical residents are increasingly avoiding states with abortion restrictions

Isabella Rosario Blum was wrapping up medical school and considering residency programs to become a family practice physician when she got some frank advice: If

May 9, 2024

What’s changed about rare disease medicine

(This is our latest issue of Post-Hoc, a dispatch of analysis and perspectives from the Endpoints newsroom. To get it directly in your inbox, you

July 24, 2024

Researchers to develop machine models to predict cardiometabolic risks in young people

A researcher at Binghamton University, State University of New York will lead a $2.5 million project from the National Institutes of Health to develop machine

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.